‘Grey’s Anatomy’ Season 14 Premiere Ends With ‘Shocking News … – Moviefone

Prepare to question everything after the "Grey's Anatomy" Season 14 premiere.

That's the scoop from Entertainment Weekly, following the recent (more welcome) news that the 2017-2018 season will be funnier and sexier than recent years.

Here's the new mini spoiler:

What do you have on Grey's Anatomy? BriannaYou may have heard that Grey's Anatomy is heading into a lighter season, but trust me when I tell you that there will be some shocking news by the end of the two-hour premiere that will really make you question, well, everything.

Very intriguing.

Everything else we've heard about Season 14 -- including the premiere, titled "Break Down the House" -- has been fresh and light.

Kevin McKidd (Dr. Owen Hunt) said the premiere is "fantastic, funny and feels like vintage" "Grey's Anatomy."

We know Teddy Altman is returning, there's a new baby Harriet on set, DeLuca's sister is showing up, Matthew Morrison's bad hubby is returning, Megan Hunt has been recast, there will be love triangles galore, and now some kind of premiere night shocker.

We're ready to scrub in! The two-hour premiere arrives Thursday, Sept. 28 on ABC.

Want more stuff like this? Like us on Facebook.

Some doctors at a hospital in Seattle -- including several who began their careers at the facility as interns -- try to balance life and work. Read More

Continued here:
'Grey's Anatomy' Season 14 Premiere Ends With 'Shocking News ... - Moviefone

Anatomy of a collapse: How Jets turned into the NFL’s worst team … – ESPN (blog)

FLORHAM PARK, N.J. -- The New York Jets used to be good. Oh yes, they were hot stuff in 2010, when they reached the AFC Championship Game for the second year in a row. They had a larger-than-life coach in Rex Ryan, who approached every game as a schoolyard brawl -- and he had the roster to back him up.

The Jets haven't left that schoolyard, though now they're being taunted and shunned, not good enough to get into any of the games.

The bully has been geekified.

After six straight years out of the playoffs, three seasons with double-digit losses, two regime changes and one year of Tim Tebow, the Jets are regarded by some experts as the worst team in the NFL. Expectations are at an all-time low. So low that members of the 1996 Jets, who finished a franchise-worst 1-15, are getting asked by friends if the current team could pull a '96. It's not far-fetched, considering they're not favored in a single game this season, according to ESPN's FPI.

Team officials say they have a long-term plan to become contenders again. Clearly, the focus is beyond this season. In a 20-minute interview this week with WFAN radio, general manager Mike Maccagnan used the phrase "going forward" a total of 28 times. Coach Todd Bowles has told players to stop talking about last season, a 5-11 disaster that left a fractured locker room.

Since the almost-Super Bowl run in 2010, the Jets are 41-55, the worst record in the AFC East and 24th in the league. As they look to the future, we'll take a moment to analyze how a once-prospering team has slipped into one of the longest postseason slumps in its star-crossed history.

It starts at the top

In 17 years under Woody Johnson's ownership, the Jets are eight games under .500. As Bill Parcells used to say, "You are what your record says you are." In Johnson's case, it's mediocrity.

His lack of conviction on football matters has thrust the franchise into an ever-changing approach to hirings and talent procurement. The most successful franchises adhere to a consistent philosophy, creating an identity and a culture. The Jets? They zig and zag more than an elite open-field runner.

Johnson has gone through periods of big spending and bold acquisitions (Brett Favre and Tebow), but he also has preached a methodical, draft-based approach to constructing the roster. He went from an aggressive, deal-making general manager (Mike Tannenbaum) to a passive, slow builder (John Idzik) to Maccagnan, who has demonstrated both traits.

As for his head coaches, Johnson has created a pendulum. He started with a players coach (Herm Edwards), turned to a disciplinarian (Eric Mangini), went back to a players coach (Ryan) and back to a disciplinarian (Bowles). One thing they have in common is their defensive-minded coaches, but that's curious, because of the team's perennial struggles on offense and inability to develop a franchise quarterback.

Mangini, for one, felt he had the franchise moving in the right direction, saying, "I know when I left there, that team was really good and they were disciplined and they had high character and they knew how to work." But he got fired when the team collapsed down the stretch of a 9-7 season in 2008, in large part because Favre's arm was injured.

Johnson has hired nine head coaches and general managers, none of whom had previous experience in his job. His biggest blunder was pairing Ryan and Idzik, a bad marriage that created a toxic environment at One Jets Drive. They had only one thing in common: Their fathers were former Jets assistant coaches. The two-year union set the franchise back years.

After six years on Ryan's loose ship, which produced many choppy moments, Johnson bought into the understated Bowles-Maccagnan tandem and went all-in with a win-now approach. The combined cash payroll in 2015 and 2016 was $331 million, third-highest in the league, according to Spotrac. With an old team, they missed the playoffs again and again, prompting an unprecedented roster overhaul. Rival executives were surprised by the radical change, saying they expected it to occur in Year 1, not Year 3.

Perhaps this time Johnson will stay committed to the youth movement. He made a strong statement in June, when he pulled rank and instructed his football people to release David Harris and Eric Decker, sources said. The moves sent shock waves through the building and were seen as salary dumps, a transparent attempt to save money ($13 million) while positioning the Jets for a high pick in 2018.

"If you want to go to the promised land, you have to go in a certain direction," Johnson said during the offseason. "I think this is a direction we've never tried in the 17 years I've been associated with the Jets. We've never gone this way."

Translation: We haven't succeeded with anything else, so why not take a shot?

By the way, Johnson will be living in the United Kingdom for the next three years as the U.S. ambassador, which means he can avoid a first-hand view of a painful rebuild.

Looking for the next Broadway Joe

The Jets haven't sent a quarterback to the Pro Bowl since Favre in 2008, and the only reason he made it was because ... well, he's Brett Favre. The single greatest reason for the team's decline is the abominable play at quarterback. From 2011-16, they ranked 29th in Total QBR (45.3), as they've gone from Mark Sanchez to Geno Smith to Ryan Fitzpatrick to (probably) Josh McCown, spanning three regimes.

Sanchez fizzled after a promising start, Smith got punched out by one of his teammates and Fitzpatrick, after a career year in 2015, imploded after the most bizarre contract dispute in recent NFL history.

The Jets have drafted six quarterbacks since 2009, one more than the Cleveland Browns, for crying out loud.

Hoping to find The One, theyve tapped into different profiles -- the charismatic leader (Sanchez), the big arm (Smith) and two projects (Christian Hackenberg and Bryce Petty). They also went outside the box -- way, way outside -- when they traded for Tebow in 2012.

The results? Uh, lets just say the Jets know how to pick future ESPN college football analysts (see: Tebow and Greg McElroy, a 2011 draft pick).

Im jealous, I never had a quarterback like you, as Rex Ryan, now an ESPN analyst, tells Tampa Bay Buccaneers star Jameis Winston in this weeks episode of Hard Knocks.

One of the Jets problems is they dont know how to develop quarterbacks. They rush them into the lineup (Sanchez and Smith) and never give them a chance to get comfortable in the same system. Theyre on their fifth offensive coordinator in the past six years, stunting the players growth with constant upheaval. In contrast, Tom Brady has been in the same system for 18 years.

The new hope is Hackenberg, a second-round pick in 2016. Unlike past regimes, the current administration is exercising patience, bringing him along at a glacial pace. Opposing scouts suspect its out of necessity, not by choice.

Hes never really been able to put it together since his special year in college [2013], said an AFC scout, speaking on the condition of anonymity.

Chances are the Jets will be in the quarterback market again next offseason. League insiders say Johnson, always enamored of star power at the position, has his eye on next years draft crop, which includes Sam Darnold, Josh Allen and Josh Rosen.

Hence, the Suck for Sam campaign among Jets fans.

Feeling a cool draft

The Jets have only eight of their own first- and second-round picks on the roster, and theres a reason for that: lousy drafting.

In many ways, the teams current swoon can be traced to the fruitless drafts from 2012-14. Of the 27 picks over the three-year span, only six remain on the roster -- three starters among them. First-round picks Quinton Coples and Dee Milliner are out of the league, and Calvin Pryor was shipped out. Intriguingly, the New England Patriots' top picks from those years -- Chandler Jones, Jamie Collins (second round) and Dominique Easley -- no longer are on the roster, but they traded Jones and Collins, receiving drafts picks in return.

Instead of having those players form the heart of the roster, the Jets have a huge void of middle-aged talent. It would be crippling for any organization, let alone one without an elite quarterback that can elevate those around him.

Theres no depth and no star power. Only one pick in the past 10 drafts has been selected to multiple Pro Bowls -- Darrelle Revis, a first-round choice in 2007. Leonard Williams (first round, 2015) is on his way to a stellar career, but you cant win a championship by drafting a star defender every decade.

Theyve used nine consecutive first-round picks on defensive players, dating to 2010 -- an utterly mind-boggling trend when you consider their offensive struggles. Their second-round history is enough to make Jets fans nauseous. The last one to make the Pro Bowl (not counting special teams) was Mark Gastineau, drafted in 1979.

In recent years, the Jets have employed different draft philosophies. Theyve drafted for need and best available. Theyve stockpiled picks and traded them away. Theyve tried it all, with minimal success.

If you cant draft, you cant win, a former general manager said. That explains why the Jets are where they are.

A Patriots obsession

It goes back to 1997 and 1998, when the Jets swiped future Hall of Famers Parcells and Curtis Martin, respectively, from the Patriots. The fascination was renewed by Ryan, who famously pledged that he had never kiss Bill Belichicks Super Bowl rings. (P.S.: He pretty much did.)

The obsession surfaced again in 2015, when the Jets reacquired Revis (and got busted for tampering) and based their offseason plan on trying to neutralize the Patriots high-powered passing attack.

Maccagnan, in his first year as GM, bought an entire secondary, bringing in Revis, Antonio Cromartie, Buster Skrine and Marcus Gilchrist. Maccagnans boss, Johnson, was giddy, thinking the Jets had weakened the Patriots by luring Revis back to their side.

Some teams acquire players to compete with a particular team, like Golden State signing Kevin Durant to take down Cleveland, the AFC scout said. I think the Jets, with Mike and Todd coming in, were trying to get guys to help them beat New England.

The Jets learned a hard and expensive lesson. They burned $39 million on Revis, whose skills had eroded appreciably. Cromartie lasted a year, Gilchrist two. Only Skrine remains from that wild spending spree. Instead of creating their own identity, the Jets have wasted time trying to copycat the Patriots.

"They don't have [an identity] anymore," a former Jets player said. "They lost it when they kicked Rex out the door."

Maccagnan & Co. tried to storm the Evil Empire, but they were thwarted at the gate. Now, two years later, the gap between the teams is larger than ever.

Link:
Anatomy of a collapse: How Jets turned into the NFL's worst team ... - ESPN (blog)

Anatomy of a Goal: The Pedro (to Ola) Connection – Massive Report

Welcome to Anatomy of a Goal, where each week we dissect one goal (or near goal) from the previous weeks Columbus Crew SC match.

For match 27 on the 2017 MLS Season, we take a look at Ola Kamaras 45th minute game opening goal, assisted by new Designated Player Pedro Santos, that put Crew SC up 1-0 as part of the 2-0 win over the LA Galaxy on Saturday.

Heres a look at the finish from the Columbus forward.

Columbus dominated the early goings of this match, with new DP Santos drawing a red card on LA left back Ashley Cole. After a missed penalty kick by Federico Higuain, it looked like the Black & Gold might be in for a match of missed opportunities, but nonetheless the team continued to possess the ball and push for a goal.

Crew SCs opening goal begins with an errant pass from LAs Gyasi Zardes to Bradford Jamieson IV. Columbus captain, Wil Trapp easily steps in front of the headed ball, denying the Galaxys attempt to move forward.

Trapp heads a ball to the Black & Golds attacking fulcrum, Higuain.

Higuain takes a few deft touches to bring the ball down, and then knocks a pass into the path of Mohammed Abu, who makes a clever run around Joao Pedro and Jonathan dos Santos.

With the ball at his feet and dos Santos shifting over to provide defensive cover, Abu can attempt a difficult through pass, or ball over the top, to Kamara, try to beat dos Santos off the dribble or slide the ball over to Santos.

Abu pushes the ball out to Santos, who has yards of space between him and the Galaxy defensive midfielder Rafael Garcia.

Santos continues forward, and has can either continue his dribble or try to slot in an early through pass to Kamara.

With Garcia backpedaling, Santos decides to continue carrying the ball up the field. Finally met with defensive resistance in the form of dos Santos, Pedro now has three options: continue his dribble and try to beat dos Santos and Garcia, chip a ball over the top to Kamara or slide the ball over to Hector Jimenez running unmarked on the right flank.

Santos plays in Jimenez, but his pass is a bit too heavily and toward the end line, leaving Jimenez and Garcia are in a footrace to the ball before it goes out of bounds.

Jimenez beats Garcia but doesnt have any room for a cross. Instead, Jimenez cycles back out toward the sideline, finding Pedro near the touch line.

With the ball, and the beginnings of a passing triangle forming, Santos can play a square pass to an open Trapp, dribble into the space vacated by Jimenez or just hold onto the ball as the play develops or knock a touch pass right back to Jimenez.

Santos holds onto the ball as Jimenez drops in behind him. As weve see many times when the Berhalter system has been executed successfully, Crew SC have a passing triangle/rondo on the sideline with Santos, Trapp and Jimenez. Dos Santos has the unenviable position of being the lone defender in the middle of the triangle.

If executed correctly, this triangle should allow Columbus three attackers to pass the ball around the defender until one of the three is able to make a move into a more valuable attacking space.

Santos begins the passing triangle with a quick touch to Trapp who continues the triangle by finding Jimenez.

Neither Garcia nor fellow LA defender Dave Romney want any part of this passing triangle, leaving dos Santos to defend by himself.

As dos Santos shifts his defensive efforts, Jimenez slides the ball back over to Santos, likely frustrating the Galaxy defender. Romney and Garcia are still content to let dos Santos defend by himself.

Trapp then cuts out of the passing triangle, attempting to take either Romney or Garcia with him, or to be left unmarked for a chipped pass. As Trapp leaves the triangle, Higuain heads over to fill in Trapps spot, forming a new triangle as Santos holds onto the ball.

Trapp takes Romney with him out of the circle as Santos slides a pass over to Higuain. As Romney leaves, Pedro replaces him as an extra defender.

When Higuain sees Santos pass, he turns up field to form a new triangle with Justin Meram and Trapp, both of whom are immediate passing options. The Black & Golds No. 10 still has Santos as a safety valve on the touch line.

Higuain sends the ball back to Santos, who is now closed down by both Garcia and Pedro.

Sensing that both LA defenders are paying attention to Santos, Higuain makes a run much like Trapps previous run, but right between Pedro and Garcia. Once again, this run should either take one of the defenders out of the play or should leave Higuain open for a chipped pass. By running between the two defenders, Higuain may be able to cause confusion as to which defender should be following him.

Higuains run does exactly that with Garcia and Pedro both attempting to defend him. Now Santos is unmarked and has multiple options: a chipped pass to Higuain, a quick pass to Trapp, he can dribble toward the center of the field or a drop ball to Abu.

With multiple yards of space created by Higuains excellent run, Santos decides to carry the ball into the middle of the field as the play develops.

As Santos carries forward, he is met with a plethora of options: a drop ball to Abu, continue his dribble into the path of Zardes, a difficult pass to Kamara (who is just to the left of the image), a through ball to Meram or a lofted ball to Higuain, who is definitely offside.

Santos decides to thread the needle with a no-look-pass that goes between Meram and Higuain and right into the path of Kamara.

Now, the question is whether Kamara was offside when the pass was played. Above is a still frame from just before the pass is played. In this frame, Higuain is definitely offside while Kamara (whose yellow shoe you can just see) appears to be even with the final defenders, Pele van Anholt, elbow.

Above is a still frame from right when the pass is played. Higuain is clearly offside. The zoomed in section shows Kamara and van Anholt at the moment the pass was played. Its very difficult to tell whether Kamara is on or offside, but he looks to be almost exactly level.

It should be noted that every goal is reviewed by the VAR and therefore it was determined that Kamara was onside and no review was needed.

Back to the goal, as the ball heads toward Kamara, he is lining up to fire a one-touch-shot on goal.

Kamara is able to turn on Santos perfectly weighted pass . . .

. . . and easily scores the game-opening goal.

Here is the original post:
Anatomy of a Goal: The Pedro (to Ola) Connection - Massive Report

‘Grey’s Anatomy’ Season 14: Sorry, Jolex, DeLuca & Jo May Still Happen – Moviefone

DeLuca got Friendzoned in "Grey's Anatomy" Season 13, but Season 14 is a whole other ballgame, and it sounds like he might not sit on the bench.

Giacomo Gianniotti recently told TVLine that "Grey's" Season 14 is going to be funnier, sexier, and more fun than recent seasons. That bar is low, but there are so many love triangles, squares, etc. happening right now that it's good to hear the show plans to go in a lighter direction with them instead of getting too dark.

We had pretty much counted out Dr. Andrew DeLuca getting with his crush Dr. Jo Wilson (Camilla Luddington), since she blew him off last season and still seems focused on her love, Dr. Alex Karev (Justin Chambers). However, the Alex/Jo story has potential to blow up -- considering Alex tracked down her abusive husband, did nothing about it, and didn't tell her -- and no one ever promised that Jolex would be End Game.

Here's more from TVLine:

Question: Any scoop on Grey's Anatomy's Jo and Alex? BrockAusiello: Don't count out interloper Andrew just yet. Even though Jo seemed meh about his infatuation with her, Giacomo Gianniotti hints that his portrayer may make another go at it. "I think he just jumped the gun a bit," the actor shares. "Jo just went through this crazy traumatic experience [with Alex]. It was so fresh. I think he should've waited a little bit. And if he does wait a little bit [before approaching her again] she might have more of an open mind."

Interesting. Last November, during Season 13, Luddington talked to EW about DeLuca and Jo, and shut the idea down:

Does Jo not realize that Andrew has feelings for her on Grey's Anatomy? I kind of 'ship it, to be honest. Helene"I really don't think she does!" Camilla Luddington says. "I think she feels in the midst of a tornado, there is so much spinning around her head that she's not picking up on any feelings. I think she's just happy to have a friend. Even if she had a question about it, I think she'd set it aside. That would complicate things and right now she's craving simplicity."

That was then, though, and a lot has happened in the meantime.

More recently, both Luddington and Gianniotti talked to TV Guide about the many love triangles ahead. Although Matthew Morrison said he was returning this season, at the time, Luddington said she hadn't read a script with her husband back in it. "It's definitely a storyline that I hope we explore, because it's so important. But right now, it's [DeLuca] and Alex." She also added that it will be interesting to see how Jo reacts when she finds out Alex tracked down her husband. "Do I think that it could push them even further away from each other? It's definitely possible."

"Grey's Anatomy" Season 14 premieres with "Break Down the House," which will reportedly have a "vintage Grey's" vibe about it, airing Thursday, Sept. 28 at 8 p.m. on ABC.

Want more stuff like this? Like us on Facebook.

Some doctors at a hospital in Seattle -- including several who began their careers at the facility as interns -- try to balance life and work. Read More

Follow this link:
'Grey's Anatomy' Season 14: Sorry, Jolex, DeLuca & Jo May Still Happen - Moviefone

Fast-tracking international surrogacy: reforming the law for parental orders – Lexology (registration)

The legal procedure for obtaining a parental order in England and Wales is complicated. It can be both confusing and expensive for applicants.

In Re Z (Foreign Surrogacy: Allocation of Work: Guidance on Parental Order Reports) [2015] EWFC 90 Russell J said that international surrogacy cases invariably involve some legal complexity. As a result, all proceedings under section 54 of the Human Fertilisation and Embryology Act 2008 (s54 HFEA 2008) where the child was born outside of England and Wales are allocated to a High Court judge.

At the moment, applications for parental orders in international cases involve two hearings. The first is a directions hearing at which the judge timetables the filing of evidence, directs a parental order report and lists a final hearing. The second is the final hearing at which the order is made, usually without complication.

However, as surrogacy has increased in popularity, so has the number of relatively straightforward cases and the need for reform is clear. Not all international cases involve legal complexity, yet the stringent rules and processes continue to apply.

In these cases, it would seem eminently sensible if the two hearings could be condensed to one. This happened in a recent case, run by Penningtons Manches partner Simon Blain, instructing Andrew Powell of 4 Paper Buildings, where only one hearing was required.

There is great potential for these fast track or composite hearings to become the norm. A case may potentially be suitable for the fast track if:

Simon Blain comments: When the court procedure for dealing with international surrogacy cases was first drawn up, these cases were regarded as rare and exotic and stringent procedures were put in place. As increasing numbers of prospective parents choose surrogacy, the process has become normalised. By using a reputable agency in the foreign country, and by consulting expert lawyers in the UK, it is possible to significantly reduce the length, and therefore the cost, of the proceedings. Of course, there will always be less straightforward cases where the full procedure will need to be followed.

See the rest here:
Fast-tracking international surrogacy: reforming the law for parental orders - Lexology (registration)

Use neuroscience to convince your boss to let you nap at work – Mashable

A nap can be a beautiful thing when we feel our brain slowly grinding to a halt. Whether its a siesta to shake off a food coma, a daytime doze on a lazy Sunday, or an all-out nap orgy with friends or loved ones, we arise feeling replenished, recharged, and ready to take action. Unfortunately, not very many bossessee any correlation between snoring and success. Onlya handful of organizationBen & Jerrys, Nike, Zappos, Google, and The Huffington Post, to name a fewcurrently see naps assmart business. Theyve invested innap pods and massage chairsbecause they know that, when it comes to boosting productivity and creativity in the workplace, naps can bejust what the doctor ordered.

If you arent among the lucky few who work for nap-friendly bosses, youve come to the right place for advice. Ima Harvard Medical School neuroscientistwho firmly believes in thepower of the unfocused mind, and my goal is to have every business on Earth including your employer embrace naps as a vital part of the workday.

First, allow me to clarify a few things and offer a bit of a disclaimer.

Not all naps are equal, and not all brains are equal. Everyone will respond differently to napping, as some brains are more energy-efficient than others. For instance, a 15-minute catnap might give Sally the salesperson three extra hours of battery life, but it will only provide Mary the marketer with one extra hour of productivity. Science also offers us some words of caution. Unhealthy napping habits may increase the risk ofdiabetes,muscle aches, andheart disease. People who uselong, frequent napsas a substitute for sleep, for example, seem to get ill more often.

On the other hand, strategic napping is scientifically proven to provide countless benefits. To get your boss on board, approach him or her with these three compelling science-backed arguments:

Employee disengagement has officially become an epidemic in America, withGallups 2017 State of the American Workplace Reportrevealing that 51 percent of todays workforce members are disengaged from their jobs. Chances are good that your employers no exception to this trend.

Your boss is probably trying to re-engage the team by preaching (and rewarding) immense focus and tireless, around-the-clock hard work. However, you need to explain to him or her that the human brainoperates at its bestwhen its encouraged to oscillate between focus and unfocus.

Though naps may not seem very engaging,brain sciencetells us a vastly different story. While youre asleep, your brainsfocus circuitsget some much-needed rest, but believe it or not, other parts of your brain kick into overdrive. In fact, the brainconsumesmoreenergyduring a nap than it does while youre awake and the bulk of this energy is devoted toward regions that promoteself-awareness and emotional control. Therefore, naps dont just help us think better; they help usfeelbetter (especiallymorning naps).

A well-rested focus circuit, paired with a greater sense of self, is a recipe for engagement in the workplace. All it takes isfive to 15 minutes per day.

In todays ever-changing business world, innovation is what keeps companies afloat. Creative energy must flow through every department, and its up to your boss to foster an atmosphere that encourages this.

Perhaps he or she bought beanbag chairs, ping-pong tables, and colorful artwork in an attempt to stimulate creative thought, but few things come close to sparking creativity like a nap does. Explain to your boss that naps will help your teamnavigate complex tasks,sharpen its thinking,andkeep a keen eye on its competition. Naps drop drawbridges between seemingly disconnected thoughts and allow for new insights to emerge.

Keep in mind, however, that in order to reap the full creative benefits of napping, its best todevote 90 minutes to each snooze. This may require a rejiggering of the workday; perhaps your company could lengthen its lunch break to promote midday napping, and then extend its office hours a bit to make up for it.

Napping helps people freshen up their ideas and gain sudden, unexpected insights. On a companywide basis, they can give a business just the creative edge it needs to thrive.

Its no coincidence that some of the worlds most endearing and innovative companies were among the first to embrace napping as a viable business strategy. This is the wave of the future, and your boss will be in great company if he or she hops aboard today. Current and prospective employees will be thrilled by the idea of working in a progressive environment that mirrors the likes of Google.

But it also goes beyond business. Some of the worlds most inspiring mindswere also known nappers. Salvador Dal, Ludwig van Beethoven, Aristotle, Albert Einstein, and Thomas Edison power-napped their way to universal reverence, and even presidentsKennedy, Reagan, and Clintonwere fans of the practice.

If your boss still doesnt see napping as legit, sign and circulate thisnap petitionamongst your co-workers. It will give your group even more cred, and your boss may be more open to listening.

Strategic napping is productivity in disguise and its time for your boss to recognize this fact. Thanks to science, we can now unmask the hidden benefits of naps and bring a whole new meaning tosleeping on the job.

Srini Pillay, M.D., is the CEO of NeuroBusiness Group and the award-winning author of numerous books, including Tinker Dabble Doodle Try: Unlock the Power of the Unfocused Mind, Life Unlocked: 7 Revolutionary Lessons to Overcome Fear, and Your Brain and Business: The Neuroscience of Great Leaders. He also serves as an assistant professor of psychiatry at Harvard Medical School and teaches in the Executive Education Program at Harvard Business School.

Here is the original post:
Use neuroscience to convince your boss to let you nap at work - Mashable

EvergreenHealth opens neuroscience, spine and orthopedic … – Kirkland Reporter

EvergreenHealth announced the grand opening of its Neuroscience, Spine & Orthopedic Institute on the health systems Kirkland campus.

The Institute spans four levels of EvergreenHealths DeYoung Pavilion and includes two newly constructed floors to house the systems musculoskeletal and orthopedics practices, providing patients with the convenience of complementary services in one location.

The two new floors on levels four and five of the DeYoung Pavilion combine innovative design and technology to enhance patient care, while also accommodating the integration of EvergreenHealths musculoskeletal and orthopedics services.

Now, from a single location, patients receive in-clinic evaluation and diagnostic care, imaging, minimally invasive procedures, surgical consultation and rehabilitation within orthopedics, spine surgery, physiatry, podiatry, neurosurgery and pain management.

The new floors join EvergreenHealths neurological care practices located on the third floor, along with a comprehensive outpatient rehabilitation services center on the second floor.

Offering comprehensive neuroscience, spine and orthopedic services under one roof further helps us to meet the growing needs of our community, said Bob Malte, CEO of EvergreenHealth in a press release. As we continue celebrating 45 years of serving Eastside residents, the opening of these two new floors reinforces our ongoing commitment to advancing the health of all patients through high quality, multidisciplinary care.

The newly built-out floors are part of EvergreenHealths 10-year Master Facility Plan approved by the organizations Board of Commissioners in July 2015 to promote growth that enables EvergreenHealth to meet the communitys evolving health care needs. When the DeYoung Pavilion opened on the Kirkland campus in 2009, it reserved its top two levels as shelled space, allowing the health system to later develop the floors in response to increased demand and community growth.

The two new floors in the Neuroscience, Spine & Orthopedic Institute feature 51 exam rooms, two imaging centers, three procedural rooms and six pre- and post- procedure rooms. The spaces were thoughtfully designed to promote healing while providing ease of access for patients of all abilities, and offers continuity between services. For example, for patients receiving procedures, the overall flow from admission to discharge moves in a forward direction, with no need for backtracking. Tablets allowing for electronic patient self-check-in make the entire process more user-friendly for patients and efficient for staff members.

This new development is the result of many years of thoughtful and innovative planning, as part of our mission to expand EvergreenHealths musculoskeletal service offerings, said Yung Lee, DO, medical director of EvergreenHealths Sport & Spine Care practice in a press release. Our team is proud to continue the journey towards a more integrated model of care that best meets the needs of our patients.

Construction and development of the new unit was made possible by generous donations from Mike and Mary Kay Hallman, The Schultz Family Foundation, and Tom and Connie Walsh.

EvergreenHealth recently celebrated other expansion efforts across the health system, including the opening of a new urgent care center in Mill Creek, and two new inpatient floors in the Silver tower on the Kirkland campus.

For more information on the Neuroscience, Spine & Orthopedic Institute and to watch a virtual tour of the space, visit https://youtu.be/7-xC_sNOy7U and http://www.northwestsportbackjoint.com.

Visit link:
EvergreenHealth opens neuroscience, spine and orthopedic ... - Kirkland Reporter

Medicine and music: Immunology major makes his own way at Penn State – Penn State News

UNIVERSITY PARK, Pa. Alex Barna, a junior from Aliquippa, Pennsylvania, has known that he wanted to be a doctor since the 7th grade. He came to Penn State with an interest in microbiology but discovered an opportunity to distinguish himself from other pre-med students in the College of Agricultural Sciences' immunology and infectious disease major.

Immunology and infectious disease students learn how the body copes with bacterial, viral or parasitic infections, cancer and other diseases. Penn State is one of only five institutions in the United States to offer an immunology major and the only one that blends the study of molecular and cellular immunology with epidemiology of infectious diseases. Barna, a third-generation Penn Stater whose grandfather also was a College of Agricultural Sciences student, says he chose the major because it seemed like a unique opportunity to study what he is interested in while preparing for medical school.

Barna hopes that his experiences will help him become not only a good doctor, but a healthcare professional with a view wider than a single patient. "A lot of doctors are being taught how to treat one patient," he said. "They can find a disease and cure what's happening, but they kind of lack the knowledge to understand populational health."

Since January, Barna has been performing undergraduate research to complement his studies. The lab he works in studies an infectious fungus that affects ants and alters their behavior so that they spread the infection to plant hosts and other ants. Barna is interested in understanding why only 10 percent of ants die when a colony becomes infected. Observing the spread of the disease through these animals is an opportunity to directly observe the populational health dynamics he has learned about in class.

He also is pursuing the selective global health minor through the College of Health and Human Development. Through this minor, he will study abroad next summer somewhere in Africa, shadowing physicians to gain an understanding of the differences and similarities between African and American healthcare.

In addition to his academic pursuits, Barna is excelling in a completely different passion music. He is a singer with Essence of Joy, a choir at Penn State dedicated to singing and preserving African-American music. "Music always has been a really huge part of my life, and I knew I didn't want to lose that coming to college, so I really made an effort to keep it a part of me," he explained.

He also is taking voice lessons for credit and has been studying with Blythe Walker, a singer with the Metropolitan Opera in New York City. "It's been really cool to learn how to sing classical music with someone who lives classical music and really understands the background and importance of it," he said.

Barna is a member of Ag Advocates, a group of high-achieving students in the college who help put together events, assist with prospective students, alumni and donors, and are overall advocates for the college. He also was one of the executive board members for Ag Day, a day for College of Agricultural Sciences clubs and organizations to advertise to the university the impact that agriculture has on everyday life.

He is part of the Tri Beta biological honor society, a national honor society to support excellence in biology and biological sciences, and has served on a Penn State Reads executive committee, where he helped plan for events related to the Penn State Reads book.

Excerpt from:
Medicine and music: Immunology major makes his own way at Penn State - Penn State News

Page Rejoins UK Gluck Center’s Immunology Group – TheHorse.com

Photo: University of Kentucky's College of Agriculture, Food, and Environment

The University of Kentucky (UK) Gluck Equine Research Center recently welcomed back Allen Page, DVM, PhD, as a scientist and veterinarian. Page completed his doctoral degree in the UK Department of Veterinary Science in 2013.

Page said he decided to come back in April after working for the USDA for more than two years because he enjoyed the collaboration with colleagues he previously worked with during his previous five years at the Gluck Center. He particularly enjoyed the challenge of research that the Gluck Center has to offer.

I think that as somebody who has been working with horses my whole life, it is something that interests me as of means of helping the horses and owners from a welfare aspect and performance aspect, he said.

In his multifaceted role at the Gluck Center, Page works as a scientist and veterinarian working with David Horohov, PhD, chair of the Department of Veterinary Science and director of the Gluck Equine Research Center. Page manages the laboratory and is also the departments clinical veterinarian, a role that has him oversee the veterinary care of the departments 300 horses. He also has a small appointment working for the universitys attending veterinarian and serves as an alternate member on the Institutional Animal Care and Use Committee, where he will help review protocols and conduct site inspections for research projects.

Before he left UK, Page was involved in a study examining inflammation in racehorses and picked up the research when he returned. He and others in the laboratory are trying to develop an easy-to-run test that will give veterinarians and researchers an idea whether horses could be at risk for injury. The laboratory has also used the test to look at young horses, primarily 2-year-olds in training, to determine how fit they are and if they are responding appropriately to increased training. This is important to the industry because it could potentially help prevent horses from suffering career- and life-ending injuries.

Page recently completed a preliminary collaborative project with researchers from Lincoln Memorial University (LMU), in Harrogate, Tennessee, where they examined the effect of stabling versus pasture management on horses and the effect the management protocols had on lipids or surfactant (the material that lines the alveoli, or air sacs of the lungs) in their lungs. Future collaborative studies with LMU hope to look at the effects of long-term stabling with horses with asthma. This research is important to the industry because barns are typically dusty, dirty, and can exacerbate asthma in those horses.

He is also currently overseeing a pilot study looking at the longevity and the effect of different equine herpesvirus-1 (EHV-1) vaccines on the immune response in horses. Because it can cause abortions in pregnant mares and potentially deadly neurologic deficits all horses, EHV is a disease of interest to many in the equine industry. Page and colleagues are studying the duration of immunity and how long horses white cells (immune cells) will appropriately respond after being challenged with EHV-1.

Page has a bachelors degree in animal science and veterinary degree from University of California, Davis. He completed a yearlong internship with Hagyard Equine Medical Institute, in Lexington, Kentucky, after he graduated from veterinary school. He then came to UK and completed his doctoral degree and postdoctoral studies where his efforts primarily involved work with Lawsonia intracellularis, a bacterial disease of weanling and yearling horses.

Katie Lampert is a marketing and communications intern at the UK Gluck Equine Research Center.

Want more articles like this? Sign up for the Bluegrass Equine Digest e-Newsletter.

More information on Gluck Equine Research Center and UK Ag Equine Programs.

See original here:
Page Rejoins UK Gluck Center's Immunology Group - TheHorse.com

Genetics for everyone – The Boston Globe

Illustration by cristina span/for the boston globe

The Greeks asked their oracles to predict future fortunes and future losses. The Romans studied the entrails of sacrificed animals for similar reasons. In modern-day medicine, though, soothsayers come in the form of genetic tests.

Ever since the human genome was sequenced almost 15 years ago, tens of thousands of genetic tests have flooded the marketplace. By analyzing someones DNA, often through a blood sample or cheek swab, these tests promise to foretell whether a patient is prone to certain cancers, blessed with the potential to become a star soccer player, or at an elevated risk of having an opioid addiction.

Advertisement

These types of genetic tests are finding an eager audience. The North American genetic testing market, already the largest in the world, was worth $11.9 billion in 2016, by one estimate, and is expected to grow at more than 15 percent a year for the foreseeable future. Companies such as LabCorp, which offer genetic tests via doctor recommendations, and the healthcare giant Roche have moved aggressively into the field. The company 23andMe, a household name because of its ancestry tests, sells health-related tests directly to consumers.

But for a source of medical information to be legally sold in the United States, just how accurate does it need to be?

Like a prediction from a crystal ball, genetic test results are sometimes wrong. Some tests that predict the likelihood a young pregnant woman will have a child with a genetic condition such as Down syndrome may only be correct only 60 percent of the time. Most genetic tests, and many other lab tests, go unvetted by the Food and Drug Administration. That means these tests may not undergo any independent review to make sure they accurately pick up the disease or genetic conditions they claim to be seeking.

Using the worlds first portable DNA lab to sequence beer is a cool thing to do.

The FDA has been wrestling for years with whether and how to do more. During the Obama administration, the agency proposed a new set of draft limits on a whole class of tests, and then put them on hold immediately after Donald Trumps election. This spring, the FDA gave 23andMe permission to market genetic screenings for susceptibility to Alzheimers, Parkinsons, and other conditions. It was the first time the agency blessed direct-to-consumer tests for genetic health risks.

While the debate over genetic testing often follows a pattern familiar from countless other industries business groups want less regulation, and consumer advocates favor more it also raises more cosmic questions: Is a medical test just a piece of information? Or is it something more, if its result leads to dramatic or irreversible action such as chemotherapy or an abortion? And if a data point is factually suspect, or ripe for misinterpretation, when and how should it be offered to consumers?

Advertisement

Especially if regulators stand aside, Americans may soon be swimming in even more tests that vary greatly in their reliability. Yet for some people contemplating a current ailment or their future well-being, getting an answer even an unreliable one may be better than no answer at all.

Especially for people expecting a baby, genetic tests can be hard to resist. I think we all are wanting to know our child doesnt have something... we want them to be healthy, said Mischa Livingstone, a filmmaker and professor who lives in California. Without asking for it, his pregnant wife, Jessica, was given a genetic test that predicted a 99 percent chance their child would have Turner syndrome, a genetic condition that can lead to short stature, heart defects, and other symptoms. But genetic tests for Turner are more often wrong than right a fact the couple didnt know at the time.

They were devastated, and immediately went for more invasive testing, which showed the fetus was fine. But their sense of dread didnt lift until their daughter, now 2 1/2, was born perfectly healthy.

Despite the heartache a faulty genetic test result caused, Livingstone says hed consider asking for one again. I think it feeds into that need for certainty, he said.

Both individuals and society as a whole are intolerant of the unknown, medical sociologists say.

Long before genetic screenings, there was a critical relationship between lab tests and medical treatment. Doctors often wont prescribe drugs or treatment without a positive test result. Insurance payments are rarely processed without diagnostic codes. The rise of genetic testing wont change, and may even amplify, that dynamic.

While some diagnoses may still carry social stigma think schizophrenia, for example they more often may confer legitimacy. Having a gene for alcoholism, for example, can make people view the problem as biological, as opposed to a character flaw. For patients, genetic tests promote a therapeutic optimism a hope that they can be treated and cured for an immediate problem or a future one, according to Michael Bury, professor emeritus at Royal Holloway, University of London, who studies society and illness.

A test alone can feel like a step forward. Undergoing a screening, said Natalie Armstrong, professor of healthcare improvement research at the University of Leicester, can make people feel that at least they are doing something proactive.

Interestingly, one study indicated that certain direct-to-consumer genetic tests dont affect users behavior or anxiety levels, bolstering the argument that people may use the information as data points, not a surefire prediction of their own fate.

Many bioethicists are unpersuaded. On an individual basis, it is tempting to discount the pitfalls of a little extra information, says Beth Peshkin, an oncology professor and genetic counselor at Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C. But on a population level the implications of inaccurate results can be costly and, sometimes, deadly.

One of the most cited examples of this harm is from a 2008 genetic test for ovarian cancer that misdiagnosed women, some of whom had their ovaries removed unnecessarily before the test was pulled from the market. Because test makers do not have to report when a test turns out to be wrong in fact many people may never know when a test result is a false positive or negative FDA officials have said it has been almost impossible to assess the overall harm from all unregulated tests.

Cost is another concern that may arise from the overuse of genetic tests that proliferate without meaningful oversight. Tests often beget more tests that cost an ever-escalating amount of money. Enough testing, will invariably pick up something abnormal in a patient, even though it may not harm them, some experts believe.

In some ways its easy for us to try and find something definitive and act on that even though it has nothing to do with what is wrong with the patient, said H. Gilbert Welch, a cancer research at Dartmouth College who has written extensively on the dangers of overtesting. Genetics is an amazing tool... but to what extent does that data predict something that you care about? Is it useful knowledge?

Get This Week in Opinion in your inbox:

Globe Opinion's must-reads, delivered to you every Sunday.

The American Clinical Laboratory Association, the key trade group for genetic test makers, and other advocates of lighter regulation argue that bad tests are rare, and that its more important for the free market to allow innovation. With more tests in place to identify disease, cures come next, they say.

So far, the public has shown little concern about the fallout of genetic testing. While a 2016 poll showed only 6 percent of American adults have undergone genetic testing, 56 percent of them said they would want to if it could predict cancer or a disease like Alzheimers. Most Americans, the poll found, believe genetic tests for predicting disease are mostly accurate and reliable.

Safety advocates best chance to tighten regulation may have already passed. The world of genetic testing becomes more free-wheeling and consumer-driven all the time. By one industry estimate, 10 new genetic testing products enter the market each day. Despite considerable skepticism from medical experts, new apps purport to use data from gene sequencing to develop personalized diet plans and fitness routines.

The FDAs now-shelved rules would have classified genetic and other tests according to how much harm they could cause if their result was wrong. For example, a new genetic test for colon cancer, which requires intrusive and costly treatment, likely would have been subject to full FDA review; the maker of a test that predicts mere baldness might only have had to register it with the agency and report any known problems with it. Under the Trump administration, the agency appears less likely to draw such distinctions or impose new restrictions at all.

People want answers soon, and their inclination is to believe what appears to be solid, unassailable medicine, said Robert Klitzman, a Columbia University bioethicist. Individuals will need to evaluate these tests carefully. The notion of being able to tell your fortune has great lure. But its a little bit of hubris. We still dont know so much.

Genetic testing, still in its infancy, promises a measure of clarity about the future of our bodies. But as genetic science rapidly evolves, that modern-day crystal ball raises vexing new questions and creates its own kind of uncertainty.

View post:
Genetics for everyone - The Boston Globe